Short bowel patients treated for two years with glucagon-like peptide 2 (GLP-2): compliance, safety, and effects on quality of life
P B Jeppesen, P Lund, I B Gottschalck, H B Nielsen, J J Holst, J Mortensen, S S Poulsen, B Quistorff, P B Mortensen
Fingerprint
Dive into the research topics of 'Short bowel patients treated for two years with glucagon-like peptide 2 (GLP-2): compliance, safety, and effects on quality of life'. Together they form a unique fingerprint.